Showing items 101–178
Method for treating a disease originated from receptor activation by EREG and TGFα
Grant US-10005832-B2
United States of America
Anti-HER2 glycoantibodies and uses thereof
Grant US-10005847-B2
United States of America
Compositions and methods for treatment and detection of cancers
Grant US-9982041-B2
United States of America
Dual FC antigen binding proteins
Grant US-9982036-B2
United States of America
Glycan conjugates and use thereof
Grant US-9981030-B2
United States of America
Compositions and methods for treatment and detection of cancers
Grant US-9975965-B2
United States of America
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant US-9931417-B2
United States of America
Human iNKT cell activation using glycolipids
Grant US-9879042-B2
United States of America
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant US-9855344-B2
United States of America
Preparations and methods for treating a GD2 positive cancer
Grant US-9840566-B2
United States of America
Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive…
Grant US-9797907-B2
United States of America
Method for treating a GD2 positive cancer
Grant US-9777068-B2
United States of America
Anti-Trop-2 antibody-drug conjugates and uses thereof
Grant US-9770517-B2
United States of America
Bispecific anti-VEGF/anti-ANG-2 antibodies
Grant US-9708396-B2
United States of America
Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP…
Grant US-9707302-B2
United States of America
Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular…
Grant US-9695233-B2
United States of America
Pro-drug form (P2PDox) of the highly potent 2-pyrrolinodoxorubicin conjugated to…
Grant US-9694088-B2
United States of America
Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibitors and/or…
Grant US-9688761-B2
United States of America
Bispecific antigen binding proteins
Grant US-9676845-B2
United States of America
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant US-9629926-B2
United States of America
Monoclonal antibodies that specifically block biological activity of a tumor antigen
Grant US-9624297-B2
United States of America
Human monoclonal antibodies against CD25
Grant US-9598493-B2
United States of America
CTLA-4 antibody dosage escalation regimens
Grant US-9573999-B2
United States of America
Humanized anti-epiregulin antibody, and cancer therapeutic agent comprising said antibody…
Grant US-9556264-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-9522959-B2
United States of America
Use of ERBB3 inhibitors in the treatment of triple negative and basal-like breast cancers
Grant US-9518130-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-9499631-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-9493574-B2
United States of America
Antibody-drug conjugates and uses thereof
Grant US-9492566-B2
United States of America
Multivalent antibodies and uses therefor
Grant US-9493579-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-9493573-B2
United States of America
Antibodies against the ectodomain of ERBB3 and uses thereof
Grant US-9487588-B2
United States of America
Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to…
Grant US-9486536-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-9481732-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-9475884-B2
United States of America
HER2/neu-specific antibodies and methods of using same
Grant US-9469692-B2
United States of America
N-cadherin: target for cancer diagnosis and therapy
Grant US-9470689-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-9458242-B2
United States of America
Antibodies against cancer target block tumor growth, angiogenesis and metastatis
Grant US-9388247-B2
United States of America
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant US-9375489-B2
United States of America
Antibody combinations and use of same for treating cancer
Application US-9358288-B2
United States of America
Pro-drug form (P2PDox) of the highly potent 2-pyrrolinodoxorubicin conjugated to…
Grant US-9283286-B2
United States of America
Compositions and methods for cancer management using antibodies binding to nucleotide…
Grant US-9267948-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-9226973-B2
United States of America
Antibodies with immune effector activity and that internalize in folate receptor alpha-posi…
Grant US-9144614-B2
United States of America
Tumor-targeting monoclonal antibodies to FZD10 and uses thereof
Grant US-9139655-B2
United States of America
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant US-9107960-B2
United States of America
Anthracycline-antibody conjugates for cancer therapy
Grant US-9107962-B2
United States of America
Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to…
Grant US-9095628-B2
United States of America
Dendritic cell tumor injection (DCTI) therapy
Application US-9089593-B2
United States of America
CTLA-4 antibody dosage escalation regimens
Grant US-9062111-B2
United States of America
Combinations of anti ErbB antibodies for the treatment of cancer
Application US-9040047-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-9028833-B2
United States of America
PRLR-specific antibody and uses thereof
Grant US-9005614-B2
United States of America
Human monoclonal antibodies against CD25
Grant US-8961968-B2
United States of America
Antibodies against ERBB3 and uses thereof
Grant US-8961966-B2
United States of America
Use of ErbB3 inhibitors in the treatment of triple negative and basal-like breast cancers
Grant US-8895001-B2
United States of America
Anthracycline-antibody conjugates for cancer therapy
Grant US-8895013-B2
United States of America
Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to…
Grant US-8877202-B2
United States of America
Anti-AREG/HB-EGF antibodies and treatment
Grant US-8846868-B2
United States of America
Human CTLA-4 antibodies and their uses
Grant US-8784815-B2
United States of America
Multivalent antibodies and uses therefor
Grant US-8722859-B2
United States of America
Fully human antibodies against N-cadherin
Grant US-8703920-B2
United States of America
N-cadherin: target for cancer diagnosis and therapy
Grant US-8663635-B2
United States of America
Methods and systems for predicting response of cells to a therapeutic agent
Grant US-8623592-B2
United States of America
Modified binding molecules comprising connecting peptides
Grant US-8603473-B2
United States of America
Compositions and methods for cancer immunotherapy
Grant US-8603482-B2
United States of America
Anthracycline-antibody conjugates for cancer therapy
Grant US-8568729-B2
United States of America
Antibodies, polypeptides and uses thereof
Grant US-8394381-B2
United States of America
Human CTLA-4 antibodies and their uses
Grant US-8318916-B2
United States of America
Imaging, diagnosis and treatment of disease
Grant US-8216584-B2
United States of America
Methods of treatment using CTLA-4 antibodies
Grant US-8142778-B2
United States of America
Antibodies with immune effector activity and that internalize in folate receptor alpha-posi…
Grant US-8124083-B2
United States of America
Immunomodulatory compounds and methods of use thereof
Grant US-7915238-B2
United States of America
Immunomodulatory compounds and methods of use thereof
Grant US-7833993-B2
United States of America
Surrogate therapeutic endpoint for anti-CTLA-4 based immunotherapy of disease
Grant US-7744875-B2
United States of America
Immunomodulatory compounds and methods of use thereof
Grant US-7560584-B2
United States of America
Showing items 101–178